Midazolam injection is indicated: intramuscularly or intravenously for preoperative sedation/anxiolysis/amnesia;, intravenously as an agent for sedation/anxiolysis/amnesia prior to or during diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography, cardiac catheterization, oncology procedures, radiologic procedures…
From the U.S. FDA-approved label for Midazolam. Full label: DailyMed.
Midazolam injection is indicated: intramuscularly or intravenously for preoperative sedation/anxiolysis/amnesia;, intravenously as an agent for sedation/anxiolysis/amnesia prior to or during diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography, cardiac catheterization, oncology procedures, radiologic procedures, suture of lacerations and other procedures either alone or in combination with other CNS depressants;, intravenously for induction of general anesthesia, before administration of other anesthetic agents. With the use of narcotic premedication, induction of anesthesia can be attained within a relatively narrow dose range and in a short period of time. Intravenous midazolam can also be used as a component of intravenous supplementation of nitrous oxide and oxygen (balanced anesthesia);, continuous intravenous infusion for sedation of intubated and mechanically ventilated patients as a component of anesthesia or during treatment in a critical care setting.
From the U.S. FDA-approved label for Midazolam. Full label: DailyMed.
Midazolam injection is a potent sedative agent that requires slow administration and individualization of dosage. Clinical experience has shown midazolam to be 3 to 4 times as potent per mg as diazepam. BECAUSE SERIOUS AND LIFE-THREATENING CARDIORESPIRATORY ADVERSE EVENTS HAVE BEEN REPORTED, PROVISION FOR MONITORING, DETECTION AND CORRECTION OF THESE REACTIONS MUST BE MADE FOR EVERY PATIENT TO WHOM MIDAZOLAM INJECTION IS ADMINISTERED, REGARDLESS OF AGE OR HEALTH STATUS.
Directions from the U.S. FDA-approved label for Midazolam — your doctor or pharmacist may advise differently.
Injectable midazolam is contraindicated in patients with a known hypersensitivity to the drug. Benzodiazepines are contraindicated in patients with acute narrow-angle glaucoma. Benzodiazepines may be used in patients with open-angle glaucoma only if they are receiving appropriate therapy. Measurements of intraocular pressure in patients without eye disease show a moderate lowering following induction with midazolam; patients with glaucoma have not been studied.
Excerpt from the U.S. FDA-approved label for Midazolam. Talk to a pharmacist or doctor before use.
Personnel and Equipment for Monitoring and Resuscitation Prior to the intravenous administration of midazolam in any dose, the immediate availability of oxygen, resuscitative drugs, age- and size-appropriate equipment for bag/valve/mask ventilation and intubation, and skilled personnel for the maintenance of a patent airway and support of ventilation should be ensured. Patients should be continuously monitored for early signs of hypoventilation, airway obstruction, or apnea, with means readily available (e.g., pulse oximetry).
Warnings and precautions excerpt from the U.S. FDA-approved label for Midazolam — not a complete list. Talk to a pharmacist or doctor before use.
See WARNINGS concerning serious cardiorespiratory events and possible paradoxical reactions. Fluctuations in vital signs were the most frequently seen findings following parenteral administration of midazolam in adults and included decreased tidal volume and/or respiratory rate decrease (23.3% of patients following intravenous and 10.8% of patients following intramuscular administration) and apnea (15.4% of patients following…
Excerpt from the U.S. FDA-approved label for Midazolam — not a complete list. Talk to a pharmacist or doctor about side effects.
5 brands · 5 makers in the NepalDoc catalog — see the full Midazolam guide →
Store at 20 to 25°C (68 to 77°F). Discard unused portion.
Storage information from the U.S. FDA-approved label for Midazolam.
What is Mezolam?
Mezolam 5mg Injection is a Midazolam medicine made by Neon Laboratories Ltd. It comes as 5mg Injection.
What is the generic name of Mezolam?
The generic name of Mezolam is Midazolam.
Which brands of Midazolam are available in Nepal?
5 brands of Midazolam are listed in the NepalDoc catalog, from 5 makers — including Benzosed 5mg/ml Injection, Dormicum Injection, Midosed 5mg Injection, Mizova 5mg Injection.
What are the side effects of Midazolam?
See WARNINGS concerning serious cardiorespiratory events and possible paradoxical reactions.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
Every NepalDoc section, one tap away.
Find doctors by specialty across Nepal.
